{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,22]],"date-time":"2026-10-22T03:34:49Z","timestamp":1792640089040,"version":"4.5.0"},"reference-count":169,"publisher":"American Society of Clinical Oncology (ASCO)","issue":"9","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["JCO"],"published-print":{"date-parts":[[2001,5,1]]},"abstract":"<jats:p>ABSTRACT: Successful pain management with opioids requires that adequate analgesia be achieved without excessive adverse effects. By these criteria, a substantial minority of patients treated with oral morphine (10% to 30%) do not have a successful outcome because of (1) excessive adverse effects, (2) inadequate analgesia, or (3) a combination of both excessive adverse effects along with inadequate analgesia. The management of excessive adverse effects remains a major clinical challenge. Multiple approaches have been described to address this problem. The clinical challenge of selecting the best option is enhanced by the lack of definitive, evidence-based comparative data. Indeed, this aspect of opioid therapeutics has become a focus of substantial controversy. This study presents evidence-based recommendations for clinical-practice formulated by an Expert Working Group of the European Association of Palliative Care (EAPC) Research Network. These recommendations highlight the need for careful evaluation to distinguish between morphine adverse effects from comorbidity, dehydration, or drug interactions, and initial consideration of dose reduction (possibly by the addition of a co analgesic). If side effects persist, the clinician should consider options of symptomatic management of the adverse effect, opioid rotation, or switching route of systemic administration. The approaches are described and guidelines are provided to aid in selecting between therapeutic options.<\/jats:p>","DOI":"10.1200\/jco.2001.19.9.2542","type":"journal-article","created":{"date-parts":[[2017,2,24]],"date-time":"2017-02-24T06:55:01Z","timestamp":1487919301000},"page":"2542-2554","source":"Crossref","is-referenced-by-count":518,"title":["Strategies to Manage the Adverse Effects of Oral Morphine: An Evidence-Based Report"],"prefix":"10.1200","volume":"19","author":[{"given":"Nathan","family":"Cherny","sequence":"first","affiliation":[{"name":"From the Cancer Pain and Palliative Medicine Service, Department of Oncology, Shaare Zedek Medical Center, Jerusalem, Israel; Rehabilitation and Palliative Care Division, National Cancer Institute, and Fondazione Floriani, Milan; Palliative Care Department, National Cancer Institute, Palermo, Italy; Countess Mountbatten House, Southampton; Department of Palliative Care, Western General Hospital, Edinburgh; Pain Research Department, Nuffield Department of Anaesthetics, University of Oxford, The Churchill..."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carla","family":"Ripamonti","sequence":"additional","affiliation":[{"name":"From the Cancer Pain and Palliative Medicine Service, Department of Oncology, Shaare Zedek Medical Center, Jerusalem, Israel; Rehabilitation and Palliative Care Division, National Cancer Institute, and Fondazione Floriani, Milan; Palliative Care Department, National Cancer Institute, Palermo, Italy; Countess Mountbatten House, Southampton; Department of Palliative Care, Western General Hospital, Edinburgh; Pain Research Department, Nuffield Department of Anaesthetics, University of Oxford, The Churchill..."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jose","family":"Pereira","sequence":"additional","affiliation":[{"name":"From the Cancer Pain and Palliative Medicine Service, Department of Oncology, Shaare Zedek Medical Center, Jerusalem, Israel; Rehabilitation and Palliative Care Division, National Cancer Institute, and Fondazione Floriani, Milan; Palliative Care Department, National Cancer Institute, Palermo, Italy; Countess Mountbatten House, Southampton; Department of Palliative Care, Western General Hospital, Edinburgh; Pain Research Department, Nuffield Department of Anaesthetics, University of Oxford, The Churchill..."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carol","family":"Davis","sequence":"additional","affiliation":[{"name":"From the Cancer Pain and Palliative Medicine Service, Department of Oncology, Shaare Zedek Medical Center, Jerusalem, Israel; Rehabilitation and Palliative Care Division, National Cancer Institute, and Fondazione Floriani, Milan; Palliative Care Department, National Cancer Institute, Palermo, Italy; Countess Mountbatten House, Southampton; Department of Palliative Care, Western General Hospital, Edinburgh; Pain Research Department, Nuffield Department of Anaesthetics, University of Oxford, The Churchill..."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marie","family":"Fallon","sequence":"additional","affiliation":[{"name":"From the Cancer Pain and Palliative Medicine Service, Department of Oncology, Shaare Zedek Medical Center, Jerusalem, Israel; Rehabilitation and Palliative Care Division, National Cancer Institute, and Fondazione Floriani, Milan; Palliative Care Department, National Cancer Institute, Palermo, Italy; Countess Mountbatten House, Southampton; Department of Palliative Care, Western General Hospital, Edinburgh; Pain Research Department, Nuffield Department of Anaesthetics, University of Oxford, The Churchill..."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Henry","family":"McQuay","sequence":"additional","affiliation":[{"name":"From the Cancer Pain and Palliative Medicine Service, Department of Oncology, Shaare Zedek Medical Center, Jerusalem, Israel; Rehabilitation and Palliative Care Division, National Cancer Institute, and Fondazione Floriani, Milan; Palliative Care Department, National Cancer Institute, Palermo, Italy; Countess Mountbatten House, Southampton; Department of Palliative Care, Western General Hospital, Edinburgh; Pain Research Department, Nuffield Department of Anaesthetics, University of Oxford, The Churchill..."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sebastiano","family":"Mercadante","sequence":"additional","affiliation":[{"name":"From the Cancer Pain and Palliative Medicine Service, Department of Oncology, Shaare Zedek Medical Center, Jerusalem, Israel; Rehabilitation and Palliative Care Division, National Cancer Institute, and Fondazione Floriani, Milan; Palliative Care Department, National Cancer Institute, Palermo, Italy; Countess Mountbatten House, Southampton; Department of Palliative Care, Western General Hospital, Edinburgh; Pain Research Department, Nuffield Department of Anaesthetics, University of Oxford, The Churchill..."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gavril","family":"Pasternak","sequence":"additional","affiliation":[{"name":"From the Cancer Pain and Palliative Medicine Service, Department of Oncology, Shaare Zedek Medical Center, Jerusalem, Israel; Rehabilitation and Palliative Care Division, National Cancer Institute, and Fondazione Floriani, Milan; Palliative Care Department, National Cancer Institute, Palermo, Italy; Countess Mountbatten House, Southampton; Department of Palliative Care, Western General Hospital, Edinburgh; Pain Research Department, Nuffield Department of Anaesthetics, University of Oxford, The Churchill..."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vittorio","family":"Ventafridda","sequence":"additional","affiliation":[{"name":"From the Cancer Pain and Palliative Medicine Service, Department of Oncology, Shaare Zedek Medical Center, Jerusalem, Israel; Rehabilitation and Palliative Care Division, National Cancer Institute, and Fondazione Floriani, Milan; Palliative Care Department, National Cancer Institute, Palermo, Italy; Countess Mountbatten House, Southampton; Department of Palliative Care, Western General Hospital, Edinburgh; Pain Research Department, Nuffield Department of Anaesthetics, University of Oxford, The Churchill..."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"name":"for the Expert Working Group of the European Association of Palliative Care Network","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"233","reference":[{"key":"R2-088297","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.312.7034.823"},{"key":"R3-088297","doi-asserted-by":"publisher","DOI":"10.7326\/0003-4819-86-6-738"},{"key":"R4-088297","doi-asserted-by":"publisher","DOI":"10.1176\/ajp.144.8.1062"},{"key":"R5-088297","doi-asserted-by":"publisher","DOI":"10.1097\/00007611-199705000-00022"},{"key":"R6-088297","doi-asserted-by":"publisher","DOI":"10.1002\/ana.410130213"},{"key":"R7-088297","doi-asserted-by":"publisher","DOI":"10.1016\/0028-3908(86)90169-3"},{"key":"R8-088297","doi-asserted-by":"crossref","unstructured":"Umans JG, Inturrisi CE: Antinociceptive activity and toxicity of meperidine and normeperidine in mice. J Pharmacol Exp Ther 223: 203,1982-206,","DOI":"10.1016\/S0022-3565(25)33313-6"},{"key":"R9-088297","doi-asserted-by":"publisher","DOI":"10.1002\/j.1552-4604.1998.tb04380.x"},{"key":"R10-088297","doi-asserted-by":"publisher","DOI":"10.1177\/026921639100500408"},{"key":"R11-088297","doi-asserted-by":"publisher","DOI":"10.1016\/S0885-3924(97)00082-1"},{"key":"R12-088297","doi-asserted-by":"publisher","DOI":"10.1016\/0304-3959(95)00180-8"},{"key":"R13-088297","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.1998.16.4.1588"},{"key":"R14-088297","doi-asserted-by":"publisher","DOI":"10.1007\/s002280050200"},{"key":"R15-088297","doi-asserted-by":"publisher","DOI":"10.1097\/00008571-199512000-00001"},{"key":"R16-088297","doi-asserted-by":"publisher","DOI":"10.1016\/0009-9236(95)90049-7"},{"key":"R17-088297","unstructured":"Lurcott G: The effects of the genetic absence and inhibition of CYP2D6 on the metabolism of codeine and its derivatives, hydrocodone and oxycodone. Anesth Prog 45: 154,1998-156,"},{"key":"R18-088297","doi-asserted-by":"publisher","DOI":"10.1093\/ageing\/18.4.258"},{"key":"R19-088297","doi-asserted-by":"publisher","DOI":"10.1159\/000213572"},{"key":"R20-088297","doi-asserted-by":"crossref","unstructured":"Bentley JB, Borel JD, Nenad RE Jr, et al: Age and fentanyl pharmacokinetics. Anesth Analg 61: 968,1982-971,","DOI":"10.1213\/00000539-198212000-00002"},{"key":"R21-088297","doi-asserted-by":"crossref","unstructured":"Rapin CH: The treatment of pain in the elderly patient: The use of oral morphine in the treatment of pain. J Palliat Care 5: 54,1989-55,","DOI":"10.1177\/082585978900500415"},{"key":"R22-088297","doi-asserted-by":"publisher","DOI":"10.1002\/(SICI)1097-0142(19980915)83:6<1244::AID-CNCR26>3.0.CO;2-4"},{"key":"R23-088297","doi-asserted-by":"publisher","DOI":"10.1016\/0304-3959(95)00128-X"},{"key":"R24-088297","doi-asserted-by":"publisher","DOI":"10.1038\/clpt.1993.127"},{"key":"R25-088297","doi-asserted-by":"publisher","DOI":"10.1016\/0885-3924(91)90961-3"},{"key":"R26-088297","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.292.6535.1548"},{"key":"R27-088297","doi-asserted-by":"publisher","DOI":"10.1111\/j.1399-6576.1993.tb03809.x"},{"key":"R28-088297","doi-asserted-by":"publisher","DOI":"10.1016\/0304-3959(94)00148-8"},{"key":"R29-088297","doi-asserted-by":"crossref","unstructured":"Neal EA, Meffin PJ, Gregory PB, et al: Enhanced bioavailability and decreased clearance of analgesics in patients with cirrhosis. Gastroenterology 77: 96,1979-102,","DOI":"10.1016\/S0016-5085(79)80017-7"},{"key":"R30-088297","doi-asserted-by":"publisher","DOI":"10.1111\/j.1445-5994.1980.tb04969.x"},{"key":"R31-088297","doi-asserted-by":"publisher","DOI":"10.1007\/BF00558076"},{"key":"R32-088297","doi-asserted-by":"crossref","unstructured":"Patwardhan RV, Johnson RF, Hoyumpa A, Jr., et al: Normal metabolism of morphine in cirrhosis. Gastroenterology 81: 1006,1981-1011,","DOI":"10.1016\/S0016-5085(81)80005-4"},{"key":"R33-088297","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2125.1990.tb03638.x"},{"key":"R34-088297","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2000.18.8.1780"},{"key":"R35-088297","doi-asserted-by":"publisher","DOI":"10.1016\/0304-3959(89)90169-3"},{"key":"R36-088297","doi-asserted-by":"crossref","unstructured":"Fallon MT, B ON: Substitution of another opioid for morphine: Opioid toxicity should be managed initially by decreasing the opioid dose. BMJ 317: 81,1998 (letter)","DOI":"10.1136\/bmj.317.7150.81"},{"key":"R37-088297","doi-asserted-by":"publisher","DOI":"10.1016\/S0885-3924(98)00081-5"},{"key":"R38-088297","doi-asserted-by":"publisher","DOI":"10.1016\/S0304-3959(97)00157-7"},{"key":"R39-088297","doi-asserted-by":"publisher","DOI":"10.1007\/BF00315271"},{"key":"R40-088297","doi-asserted-by":"publisher","DOI":"10.1016\/0952-8180(92)90130-S"},{"key":"R41-088297","doi-asserted-by":"publisher","DOI":"10.1016\/0304-3959(95)00017-M"},{"key":"R42-088297","doi-asserted-by":"publisher","DOI":"10.1016\/S0889-8588(05)70329-4"},{"key":"R43-088297","doi-asserted-by":"publisher","DOI":"10.1016\/0304-3959(95)00044-S"},{"key":"R44-088297","doi-asserted-by":"publisher","DOI":"10.1016\/0360-3016(92)90565-Y"},{"key":"R45-088297","doi-asserted-by":"publisher","DOI":"10.1002\/(SICI)1097-0142(19971015)80:8+<1628::AID-CNCR13>3.0.CO;2-1"},{"key":"R46-088297","doi-asserted-by":"publisher","DOI":"10.1002\/(SICI)1098-2388(199801\/02)14:1<64::AID-SSU8>3.0.CO;2-0"},{"key":"R47-088297","doi-asserted-by":"publisher","DOI":"10.1016\/S1042-3680(18)30376-0"},{"key":"R48-088297","doi-asserted-by":"publisher","DOI":"10.1016\/0360-3016(92)90567-2"},{"key":"R49-088297","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.304.6818.35"},{"key":"R50-088297","doi-asserted-by":"publisher","DOI":"10.1007\/978-3-642-82028-1_19"},{"key":"R51-088297","doi-asserted-by":"publisher","DOI":"10.1002\/1097-0142(19851101)56:9<2175::AID-CNCR2820560906>3.0.CO;2-3"},{"key":"R52-088297","unstructured":"Rothenberg ML: New developments in chemotherapy for patients with advanced pancreatic cancer. Oncology (Huntingt) 10: 18,1996-22,"},{"key":"R53-088297","doi-asserted-by":"crossref","unstructured":"Thatcher N, Anderson H, Betticher DC, et al: Symptomatic benefit from gemcitabine and other chemotherapy in advanced non-small cell lung cancer: Changes in performance status and tumour-related symptoms. Anticancer Drugs 6: 39,1995-48, (suppl 6)","DOI":"10.1097\/00001813-199512006-00007"},{"key":"R54-088297","doi-asserted-by":"publisher","DOI":"10.1097\/00005392-199707000-00015"},{"key":"R55-088297","doi-asserted-by":"publisher","DOI":"10.1148\/radiology.198.3.8628867"},{"key":"R56-088297","doi-asserted-by":"publisher","DOI":"10.1002\/bjs.1800831402"},{"key":"R57-088297","unstructured":"Jong P, Sturgeon J, Jamieson CG: Benefit of palliative surgery for bowel obstruction in advanced ovarian cancer. Can J Surg 38: 454,1995-457,"},{"key":"R58-088297","unstructured":"Tarn TS, Lee TS: Surgical treatment of metastatic tumors of the long bones. Chung Hua I Hsueh Tsa Chih 54: 170,1994-175,"},{"key":"R59-088297","doi-asserted-by":"publisher","DOI":"10.1097\/00003086-199611000-00030"},{"key":"R60-088297","doi-asserted-by":"publisher","DOI":"10.1007\/978-3-642-82028-1_18"},{"key":"R61-088297","doi-asserted-by":"publisher","DOI":"10.1080\/02688699650040485"},{"key":"R62-088297","doi-asserted-by":"publisher","DOI":"10.1097\/00001622-199605000-00002"},{"key":"R63-088297","doi-asserted-by":"publisher","DOI":"10.1007\/BF02221443"},{"key":"R64-088297","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2000.18.6.1378"},{"key":"R65-088297","doi-asserted-by":"publisher","DOI":"10.1016\/S0304-3959(98)00135-3"},{"key":"R66-088297","doi-asserted-by":"publisher","DOI":"10.3109\/07853899708998741"},{"key":"R67-088297","unstructured":"Takeda F: Japanese field-testing of WHO guidelines. PRN Forum 4: 4,1985-5,"},{"key":"R68-088297","doi-asserted-by":"publisher","DOI":"10.1002\/1097-0142(19870215)59:4<850::AID-CNCR2820590432>3.0.CO;2-1"},{"key":"R69-088297","doi-asserted-by":"publisher","DOI":"10.1016\/0885-3924(88)90160-1"},{"key":"R70-088297","doi-asserted-by":"publisher","DOI":"10.1016\/S0885-3924(05)80006-5"},{"key":"R71-088297","doi-asserted-by":"publisher","DOI":"10.1177\/030089168907500513"},{"key":"R72-088297","doi-asserted-by":"publisher","DOI":"10.1016\/0885-3924(91)90039-7"},{"key":"R73-088297","doi-asserted-by":"publisher","DOI":"10.1046\/j.1525-1497.1998.00053.x"},{"key":"R74-088297","doi-asserted-by":"publisher","DOI":"10.1016\/S0304-3959(97)00018-3"},{"key":"R75-088297","doi-asserted-by":"publisher","DOI":"10.1002\/(SICI)1097-0142(19960815)78:4<852::AID-CNCR23>3.0.CO;2-T"},{"key":"R76-088297","doi-asserted-by":"publisher","DOI":"10.1016\/0885-3924(95)00005-J"},{"key":"R77-088297","doi-asserted-by":"publisher","DOI":"10.1002\/1097-0142(19951001)76:7<1283::AID-CNCR2820760728>3.0.CO;2-0"},{"key":"R78-088297","doi-asserted-by":"publisher","DOI":"10.1016\/0885-3924(95)90924-C"},{"key":"R79-088297","doi-asserted-by":"publisher","DOI":"10.1016\/0885-3924(95)00011-M"},{"key":"R80-088297","doi-asserted-by":"publisher","DOI":"10.1016\/0304-3959(92)90192-E"},{"key":"R81-088297","doi-asserted-by":"publisher","DOI":"10.1016\/S0304-3959(97)00118-8"},{"key":"R82-088297","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.1998.16.10.3216"},{"key":"R83-088297","doi-asserted-by":"publisher","DOI":"10.1016\/0885-3924(96)00050-4"},{"key":"R84-088297","doi-asserted-by":"publisher","DOI":"10.1016\/0304-3959(96)03112-0"},{"key":"R85-088297","doi-asserted-by":"publisher","DOI":"10.1016\/0304-3959(95)00084-6"},{"key":"R86-088297","doi-asserted-by":"publisher","DOI":"10.5694\/j.1326-5377.1999.tb126885.x"},{"key":"R87-088297","doi-asserted-by":"publisher","DOI":"10.1016\/S0885-3924(97)00001-8"},{"key":"R88-088297","doi-asserted-by":"crossref","unstructured":"Makin MK, Ellershaw JE: Substitution of another opioid for morphine: Methadone can be used to manage neuropathic pain related to cancer. BMJ 317: 81,1998 (letter)","DOI":"10.1136\/bmj.317.7150.81"},{"key":"R89-088297","doi-asserted-by":"publisher","DOI":"10.1002\/(SICI)1097-0142(19991101)86:9<1856::AID-CNCR30>3.0.CO;2-G"},{"key":"R90-088297","doi-asserted-by":"crossref","unstructured":"Rossi GC, Leventhal L, Pan YX, et al: Antisense mapping of MOR-1 in rats: Distinguishing between morphine and morphine-6 beta-glucuronide antinociception. J Pharmacol Exp Ther 281: 109,1997-114,","DOI":"10.1016\/S0022-3565(24)36555-3"},{"key":"R91-088297","doi-asserted-by":"crossref","unstructured":"Leventhal L, Stevens LB, Rossi GC, et al: Antisense mapping of the MOR-1 opioid receptor clone: Modulation of hyperphagia induced by DAMGO. J Pharmacol Exp Ther 282: 1402,1997-1407,","DOI":"10.1016\/S0022-3565(24)36914-9"},{"key":"R92-088297","doi-asserted-by":"publisher","DOI":"10.1016\/S0014-5793(97)00710-2"},{"key":"R93-088297","doi-asserted-by":"crossref","unstructured":"Blake AD, Bot G, Li S, et al: Differential agonist regulation of the human kappa-opioid receptor. J Neurochem 68: 1846,1997-1852,","DOI":"10.1046\/j.1471-4159.1997.68051846.x"},{"key":"R94-088297","doi-asserted-by":"publisher","DOI":"10.1016\/0304-3940(96)12976-1"},{"key":"R95-088297","doi-asserted-by":"publisher","DOI":"10.1016\/0014-5793(95)00757-Z"},{"key":"R96-088297","doi-asserted-by":"publisher","DOI":"10.1016\/S0165-6147(00)89068-9"},{"key":"R97-088297","doi-asserted-by":"publisher","DOI":"10.1111\/j.1749-6632.1995.tb17493.x"},{"key":"R98-088297","doi-asserted-by":"publisher","DOI":"10.1097\/00002826-199302000-00001"},{"key":"R99-088297","doi-asserted-by":"publisher","DOI":"10.1016\/0304-3959(88)90095-4"},{"key":"R100-088297","doi-asserted-by":"crossref","unstructured":"Brosen K, Sindrup SH, Skjelbo E, et al: Role of genetic polymorphism in psychopharmacology: An update. Psychopharmacol Ser 10: 199,1993-211,","DOI":"10.1007\/978-3-642-78010-3_19"},{"key":"R101-088297","doi-asserted-by":"publisher","DOI":"10.1016\/S0009-9236(98)90051-0"},{"key":"R102-088297","doi-asserted-by":"crossref","unstructured":"Kirkwood LC, Nation RL, Somogyi AA: Characterization of the human cytochrome P450 enzymes involved in the metabolism of dihydrocodeine. Br J Clin Pharmacol 44: 549,1997-555,","DOI":"10.1046\/j.1365-2125.1997.t01-1-00626.x"},{"key":"R103-088297","doi-asserted-by":"publisher","DOI":"10.1016\/0304-3959(93)90229-I"},{"key":"R104-088297","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.1998.16.10.3213"},{"key":"R105-088297","doi-asserted-by":"publisher","DOI":"10.1016\/0304-3959(89)90020-1"},{"key":"R107-088297","doi-asserted-by":"crossref","unstructured":"Galway JE, Morrison JD, Dundee JW: Dosage-side-effect relationships of morphine and meperidine. Anesth Analg 52: 536,1973-541,","DOI":"10.1213\/00000539-197307000-00009"},{"key":"R108-088297","doi-asserted-by":"publisher","DOI":"10.1038\/clpt.1987.47"},{"key":"R109-088297","doi-asserted-by":"publisher","DOI":"10.1093\/ajhp\/56.10.1009"},{"key":"R110-088297","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.1998.16.10.3238"},{"key":"R111-088297","doi-asserted-by":"crossref","unstructured":"Hanks GW, Forbes K: Opioid responsiveness. Acta Anaesthesiol Scand 41: 154,1997-158,","DOI":"10.1111\/j.1399-6576.1997.tb04630.x"},{"key":"R112-088297","doi-asserted-by":"crossref","unstructured":"Hanks GW, WM ON, Simpson P, et al: The cognitive and psychomotor effects of opioid analgesics: II. A randomized controlled trial of single doses of morphine, lorazepam and placebo in healthy subjects. Eur J Clin Pharmacol 48: 455,1995-460,","DOI":"10.1007\/BF00194334"},{"key":"R113-088297","doi-asserted-by":"publisher","DOI":"10.1016\/0885-3924(92)90059-Q"},{"key":"R114-088297","doi-asserted-by":"publisher","DOI":"10.1016\/S0885-3924(98)80004-3"},{"key":"R115-088297","doi-asserted-by":"publisher","DOI":"10.1016\/S0885-3924(97)00012-2"},{"key":"R116-088297","unstructured":"Wong JO, Chiu GL, Tsao CJ, et al: Comparison of oral controlled-release morphine with transdermal fentanyl in terminal cancer pain. Acta Anaesthesiol Sin 35: 25,1997-32,"},{"key":"R117-088297","unstructured":"Levy MH, Fitzmartin R, Reder R: Comparison of immediate vs controlled release morphine (MS Contin) in the long-term management of cancer-related pain. Proc Am Soc Clin Oncol 12: 455,1993 (abstr 1582)"},{"key":"R118-088297","doi-asserted-by":"publisher","DOI":"10.1016\/0885-3924(92)90018-D"},{"key":"R119-088297","doi-asserted-by":"publisher","DOI":"10.1097\/00000421-199206000-00018"},{"key":"R120-088297","doi-asserted-by":"publisher","DOI":"10.1038\/clpt.1990.85"},{"key":"R121-088297","unstructured":"Homesley HD: Morphine: immediate release vs. controlled release. N C Med J 50: 390,1989-394,"},{"key":"R122-088297","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.1995.13.4.1004"},{"key":"R123-088297","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.1995.13.6.1520"},{"key":"R125-088297","doi-asserted-by":"publisher","DOI":"10.1191\/026921698674125048"},{"key":"R126-088297","doi-asserted-by":"publisher","DOI":"10.1016\/S0885-3924(98)00080-3"},{"key":"R127-088297","doi-asserted-by":"publisher","DOI":"10.1177\/026921639601000208"},{"key":"R128-088297","doi-asserted-by":"crossref","unstructured":"Sykes NP: Oral naloxone in opioid-associated constipation. Lancet 337: 1475,1991","DOI":"10.1016\/0140-6736(91)93162-3"},{"key":"R129-088297","doi-asserted-by":"publisher","DOI":"10.1038\/clpt.1992.106"},{"key":"R130-088297","doi-asserted-by":"publisher","DOI":"10.1016\/S0885-3924(99)00086-X"},{"key":"R131-088297","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM197703312961303"},{"key":"R132-088297","unstructured":"Bruera E, Chadwick S, Brenneis C, et al: Methylphenidate associated with narcotics for the treatment of cancer pain. Cancer Treat Rep 71: 67,1987-70,"},{"key":"R133-088297","doi-asserted-by":"crossref","unstructured":"Bruera E, Brenneis C, Paterson AH, et al: Narcotics plus methylphenidate (Ritalin) for advanced cancer pain. Am J Nurs 88: 1555,1988-1556,","DOI":"10.1097\/00000446-198811000-00026"},{"key":"R134-088297","doi-asserted-by":"publisher","DOI":"10.1016\/0885-3924(89)90057-2"},{"key":"R135-088297","doi-asserted-by":"publisher","DOI":"10.1016\/0304-3959(92)90053-E"},{"key":"R136-088297","doi-asserted-by":"publisher","DOI":"10.1016\/0304-3959(92)90114-Q"},{"key":"R137-088297","doi-asserted-by":"publisher","DOI":"10.1007\/BF00365854"},{"key":"R138-088297","doi-asserted-by":"publisher","DOI":"10.1016\/0885-3924(94)90165-1"},{"key":"R139-088297","doi-asserted-by":"publisher","DOI":"10.1016\/0885-3924(92)90074-R"},{"key":"R140-088297","doi-asserted-by":"publisher","DOI":"10.1016\/S0735-6757(97)90119-4"},{"key":"R141-088297","doi-asserted-by":"crossref","unstructured":"Bieniek SA, Ownby RL, Penalver A, et al: A double-blind study of lorazepam versus the combination of haloperidol and lorazepam in managing agitation. Pharmacotherapy 18: 57,1998-62,","DOI":"10.1002\/j.1875-9114.1998.tb03827.x"},{"key":"R142-088297","doi-asserted-by":"publisher","DOI":"10.1177\/106002809502907-806"},{"key":"R143-088297","doi-asserted-by":"publisher","DOI":"10.1097\/00004850-199705000-00009"},{"key":"R144-088297","unstructured":"Lenox RH, Newhouse PA, Creelman WL, et al: Adjunctive treatment of manic agitation with lorazepam versus haloperidol: a double-blind study. J Clin Psychiatry 53: 47,1992-52,"},{"key":"R145-088297","unstructured":"Fernandez F, Holmes VF, Adams F, et al: Treatment of severe, refractory agitation with a haloperidol drip. J Clin Psychiatry 49: 239,1988-241,"},{"key":"R146-088297","doi-asserted-by":"publisher","DOI":"10.1007\/BF01788847"},{"key":"R147-088297","doi-asserted-by":"publisher","DOI":"10.1007\/BF01788841"},{"key":"R148-088297","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.299.6692.150"},{"key":"R149-088297","doi-asserted-by":"publisher","DOI":"10.1002\/1097-0142(19850801)56:3<696::AID-CNCR2820560343>3.0.CO;2-8"},{"key":"R150-088297","doi-asserted-by":"publisher","DOI":"10.1097\/00000542-199004000-00025"},{"key":"R151-088297","doi-asserted-by":"publisher","DOI":"10.1007\/BF03045086"},{"key":"R152-088297","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2044.1988.tb09020.x"},{"key":"R153-088297","doi-asserted-by":"publisher","DOI":"10.1016\/0304-3959(91)90225-M"},{"key":"R154-088297","doi-asserted-by":"publisher","DOI":"10.1016\/0304-3959(92)90146-3"},{"key":"R155-088297","unstructured":"Obeso JA: Therapy of myoclonus. Clin Neurosci 3: 253,1995-257,"},{"key":"R156-088297","doi-asserted-by":"publisher","DOI":"10.1016\/S0025-6196(11)63006-1"},{"key":"R157-088297","doi-asserted-by":"publisher","DOI":"10.1177\/106002809502900105"},{"key":"R158-088297","doi-asserted-by":"publisher","DOI":"10.1016\/S0885-3924(97)00001-8"},{"key":"R159-088297","doi-asserted-by":"crossref","unstructured":"Mercadante S: Dantrolene treatment of opioid-induced myoclonus. Anesth Analg 81: 1307,1995-1308,","DOI":"10.1213\/00000539-199512000-00034"},{"key":"R160-088297","doi-asserted-by":"publisher","DOI":"10.1016\/S0885-3924(98)00048-7"},{"key":"R161-088297","doi-asserted-by":"publisher","DOI":"10.1097\/00000542-198502000-00005"},{"key":"R162-088297","doi-asserted-by":"publisher","DOI":"10.1016\/1053-0770(91)90123-B"},{"key":"R163-088297","doi-asserted-by":"publisher","DOI":"10.1016\/S0885-3924(98)00115-8"},{"key":"R164-088297","doi-asserted-by":"publisher","DOI":"10.1038\/clpt.1993.149"},{"key":"R165-088297","doi-asserted-by":"publisher","DOI":"10.1016\/S0885-3924(96)00329-6"},{"key":"R166-088297","doi-asserted-by":"publisher","DOI":"10.1111\/j.1600-0773.1990.tb00838.x"},{"key":"R167-088297","doi-asserted-by":"publisher","DOI":"10.1016\/S0304-3959(96)03213-7"},{"key":"R168-088297","doi-asserted-by":"publisher","DOI":"10.1016\/S0885-3924(99)00036-6"},{"key":"R169-088297","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.1998.16.10.3222"},{"key":"R170-088297","doi-asserted-by":"publisher","DOI":"10.1016\/S0304-3959(97)00072-9"},{"key":"R171-088297","doi-asserted-by":"publisher","DOI":"10.1177\/082585979601200110"},{"key":"R172-088297","doi-asserted-by":"publisher","DOI":"10.1016\/0885-3924(94)00068-V"}],"container-title":["Journal of Clinical Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/ascopubs.org\/doi\/pdfdirect\/10.1200\/JCO.2001.19.9.2542","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,6,15]],"date-time":"2025-06-15T17:21:42Z","timestamp":1750008102000},"score":1,"resource":{"primary":{"URL":"https:\/\/ascopubs.org\/doi\/10.1200\/JCO.2001.19.9.2542"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2001,5,1]]},"references-count":169,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2001,5,1]]}},"alternative-id":["10.1200\/JCO.2001.19.9.2542"],"URL":"https:\/\/doi.org\/10.1200\/jco.2001.19.9.2542","relation":{},"ISSN":["0732-183X","1527-7755"],"issn-type":[{"value":"0732-183X","type":"print"},{"value":"1527-7755","type":"electronic"}],"subject":[],"published":{"date-parts":[[2001,5,1]]}}}